333D Ltd Posts Positive Operating Cash Flow and Scales Healthcare Digital Platform

Cash Flow Turnaround and Revenue Momentum

333D Ltd (ASX:T3D) delivered a notable financial turnaround in the March 2026 quarter, reporting a positive net operating cash flow of $71,505 after a $99,180 outflow in the previous quarter. This improvement was underpinned by $231,702 in cash receipts from customers, reflecting sustained growth in licence and service fee revenues from digital asset management contracts focused on healthcare.

The company’s digital asset platform, which specialises in managing DICOM-based medical imaging and 3D data, continues to gain traction. This revenue momentum reinforces the scalability of 333D’s business model, with recurring income streams emerging from healthcare sector contracts. The company’s strategic focus on healthcare digital assets positions it at the intersection of medical imaging, AI-enabled data processing, and digital infrastructure.

Strategic Bitcoin Holding and Liquidity Position

Alongside operating cash flow, 333D maintains a Bitcoin treasury valued at $214,177 as of 22 April 2026, held as a long-term strategic asset. Combined with cash and cash equivalents of $807,833, the company’s total liquidity stands at just over $1 million. This Bitcoin holding builds on the company’s earlier cryptocurrency investments, which featured prominently in its capital management strategy over the past year, including a strategic Bitcoin investment reported in February.

Capital Deployment to Scale Healthcare Platform

Subsequent to the quarter’s end, 333D invested $95,800 in capital equipment aimed at scaling its healthcare digital asset platform. This targeted deployment is intended to enhance digital asset management capabilities and support anticipated growth in licence and service contracts. The investment follows a pattern of measured capital expenditure aligned with the company’s strategic priorities in healthcare technology.

Expenditure for the quarter totalled $160,197, including $147,613 in service and operating costs and $21,040 in staff costs. Payments to related parties amounted to $77,770, primarily comprising director fees and accounting services, which investors should monitor for governance considerations.

Outlook Considerations

While 333D has demonstrated operational cash flow improvement and revenue growth in a niche sector, the company did not provide explicit forward guidance or a use of funds statement covering this quarter. Investors may watch for consistency in recurring revenue streams and the effectiveness of recent capital investments in upcoming reports. The company’s dual strategy of healthcare digital asset innovation combined with cryptocurrency holdings presents an intriguing, if complex, growth narrative.